<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="1-part\PMC6609026\results\search\funders\results.xml">
  <result pre="– review &amp;amp; editing12[1], Division of Virology, Department of Pathology," exact="University of Cape Town," post="Cape Town, South Africa[2], National Health Laboratory Service, Cape"/>
  <result pre="South Africa[2], National Health Laboratory Service, Cape Town, South Africa[3]," exact="World Health Organization," post="Geneva, SwitzerlandDarlixJean-Luc EPHEditor[], &quot;INSERM&quot;, FRANCE Competing Interests: The authors"/>
  <result pre="primary tube EDTA or PPT samples is performed on the" exact="Roche" post="Cobas AmpliPrep, Cobas TaqMan (CAP/CTM) version 2.0 assay. Using"/>
  <result pre="separately. Ethics approval for the study was obtained from the" exact="University of Cape Town" post="Human Research Ethics Committee, reference number HREC 159/2019. Results"/>
  <result pre="10.1128/JCM.00519-0919420166 10GiordanoM, KelleherT, ColonnoRJ, LazzarinA, SquiresK. The effects of the" exact="Roche" post="AMPLICOR HIV-1 MONITOR® UltraSensitive Test versions 1.0 and 1.5"/>
 </snippets>
</snippetsTree>
